NCT04001855 Evaluating the Effect of Bathing Additives in Atopic Dermatitis Status TERMINATED Phase NA
NCT03981926 Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis Status COMPLETED Phase NA
NCT03976622 Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata Status UNKNOWN Phase N/A
NCT03961529 Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03954158 Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03952559 A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03948334 A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients Status TERMINATED Phase PHASE2
NCT03936335 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) Status RECRUITING Phase N/A
NCT03921411 A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT03920852 A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03916081 Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03915496 Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03912259 Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03911401 Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03908970 Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome Status COMPLETED Phase PHASE3
NCT03903822 Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2